Yes, rapid improvement in glycemic control with any diabetes medication can occasionally trigger treatment-induced neuropathy of diabetes, which presents as acute painful neuropathy and typically improves over time
A 52-year-old man with long-standing type 2 diabetes mellitus (T2DM), obesity (BMI 36 kg/m), and hypertension was followed in a primary care clinic for suboptimal glycemic control
It is also essential for enhancing immune system health and combating cellular damage
182,183,184 Among these, glucagon-like peptide-1 receptor (GLP-1R) agonists have garnered significant attention as promising metabolic interventions
Wara AK, Wang S, Wu C, Fang F, Haemmig S, Weber BN, Aydogan CO, Tesmenitsky Y, Aliakbarian H, Hawse JR, Subramaniam M, Zhao L, Sage PT, Tavakkoli A, Garza A, Lynch L, Banks AS, Feinberg MW